JW LIFESCIENCE CORPORATION Logo

JW LIFESCIENCE CORPORATION

Specialized manufacturer of infusion solutions and advanced nutrient IV fluids.

234080 | KO

Overview

Corporate Details

ISIN(s):
KR7234080000
LEI:
Country:
South Korea
Address:
충청남도 당진시 송악읍 한진1길 28, 당진시

Description

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
기타경영사항(자율공시) (배당기준일 변경 안내)
Korean 5.8 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-08-26 00:00
[기재정정]분기보고서 (2025.03)
Korean 1.2 MB
2025-08-26 00:00
[기재정정]반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-01 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-08 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-03-26 00:00
정기주주총회결과
Korean 24.3 KB
2025-03-26 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 495.7 KB
2025-03-17 00:00
감사보고서제출
Korean 21.0 KB
2025-02-25 00:00
주주총회소집공고
Korean 103.0 KB
2025-02-25 00:00
의결권대리행사권유참고서류
Korean 87.7 KB
2025-02-19 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 16.1 KB

Automate Your Workflow. Get a real-time feed of all JW LIFESCIENCE CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JW LIFESCIENCE CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JW LIFESCIENCE CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.